Impact of diabetes control status on anastomotic leakage after esophagectomy for esophageal cancer

Risk factors for operative morbidity and mortality after esophagectomy for esophageal cancer - Risk factors for operative morbidity and mortality after esophagectomy for esophageal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047458

Enrollment

2000

Registered

2022-04-11

Start date

2021-01-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A two-center database (2011-2019) was retrospectively reviewed to identify patients with esophageal cancer who underwent esophagectomy.

Exclusion criteria

Exclusion criteria: Patients who underwent two-stage reconstruction or who were missing HbA1c values were excluded from the study.

Design outcomes

Primary

Measure	Time frame
the occurrence of anastomotic leakage	—

Secondary

Measure	Time frame
surgical site infection, respiratory complications, cardiovascular complications, operative morbidity, operative mortality, and length of hospital stay after surgery	—

Countries

Japan

Contacts

Public ContactJunya Oguma

National Cancer Center Hospital Division of Esophageal Surgery

joguma@ncc.go.jp+81-3-3542-2511

Outcome results